Tag Archives: heart failure

An innovative non-invasive imaging technique unveiled by University of East Anglia researchers can create detailed 4D flow images of the heart

(PRESS RELEASE) NORWICH, 27-Jun-2022 — /EuropaWire/ — University of East Anglia, a public research university based in Norwich, England, has announced an innovative non-invasive imaging technique developed by its researchers that can create detailed 4D flow images of the heart. … Read the full press release

Eine innovative nicht-invasive Bildgebungstechnik, die von Forschern der University of East Anglia vorgestellt wurde, kann detaillierte 4D-Flussbilder des Herzens erstellen

(PRESSEMITTEILUNG) NORWICH, 27-Jun-2022 — /EuropaWire/ — Die University of East Anglia, eine öffentliche Forschungsuniversität mit Sitz in Norwich, England, hat eine von ihr entwickelte innovative nicht-invasive Bildgebungstechnik angekündigt Forscher, die detaillierte 4D-Flussbilder des Herzens erstellen können. Die hochmoderne Bildgebungstechnologie kann … Read the full press release

Transthyretin amyloid cardiomyopathy: Alexion granted an exclusive worldwide licence to develop, manufacture and commercialise NI006 as part of an agreement with Neurimmune AG

Investigational human monoclonal antibody in Phase Ib development for the treatment of transthyretin amyloid cardiomyopathy, a systemic, progressive and fatal condition (PRESS RELEASE) CAMBRIDGE, 7-Jan-2022 — /EuropaWire/ — AstraZeneca (LON: AZN), a British-Swedish multinational pharmaceutical and biotechnology company, has announced … Read the full press release

Hyperkalaemia: Japan’s Ministry of Health, Labour and Welfare has approved AstraZeneca’s Lokelma

Hyperkalaemia - Japan’s Ministry of Health, Labour and Welfare has approved AstraZeneca’s Lokelma

(PRESS RELEASE) CAMBRIDGE, 26-Mar-2020 — /EuropaWire/ — Science-led biopharmaceutical group AstraZeneca (LSE/STO/NYSE: AZN) has announced that its Lokelma (sodium zirconium cyclosilicate) is now approved in Japan. It is used for the treatment of patients with hyperkalaemia (elevated levels of potassium … Read the full press release

University of Leicester Professor Iain Squire is UK lead in testing treatment for patients with heart failure

Leicester, UK, 15-12-2014 — /EuropaWire/ — A team from the University of Leicester and Leicester’s Hospitals has played a vital role in identifying a new treatment for reducing the risk of death or emergency hospital admission among patients with serious … Read the full press release